医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (2): 240-243    DOI: 10.3969/j.issn.1671-7171.2024.02.023
  论著 本期目录 | 过刊浏览 | 高级检索 |
不同剂量布地奈德联合沙丁胺醇治疗支气管哮喘急性发作的临床疗效
许蕊a, 宋丹b*
西安国际医学中心医院:a.重症医学科;b.呼吸内科监护室,陕西 西安 710100
Efficacy of Different Doses of Budesonide Combined with Salbutamol in the Treatment of Acute Attack of Bronchial Asthma
XU Rui, SONG Dan
Department of Critical Care Medicine, Xi'an International Medical Center Hospital, Xi'an Shaanxi 710100
全文: PDF (1190 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨不同剂量布地奈德联合沙丁胺醇治疗支气管哮喘急性发作患者的临床疗效。【方法】选取2019年10月至2020年10月在本院诊治的106例支气管哮喘急性发作患者,按照随机数字表法分成对照组(采用小剂量布地奈德联合沙丁胺醇治疗)和观察组(采用大剂量布地奈德联合沙丁胺醇治疗),每组53例。比较两组疗效、不良反应发生率及治疗前后哮喘症状评分、血清炎症因子[超敏C反应蛋白(hs-CRP)、缺氧诱导因子-1α(HIF-1α)、肿瘤坏死因子-α (TNF-α) 和白细胞介素 6 (IL-6)]水平、肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、呼吸峰流速值(PEF)]。【结果】观察组治疗总有效率为90.57%,显著高于对照组的75.47%(P<0.05)。治疗后,观察组日间、夜间哮喘症状评分及血清hs-CRP、HIF-1α、TNF-α、IL-6低于对照组(P<0.05),FVC、FEV1、PEF高于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。【结论】采用大剂量布地奈德联合沙丁胺醇治疗支气管哮喘急性发作患者,疗效显著,可明显改善其支气管哮喘症状,下调hs-CRP、HIF-1α、TNF-α、IL-6水平,改善患者肺功能,且安全性良好。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
许蕊
宋丹
关键词 哮喘/药物疗法急性病沙丁胺醇/投药和剂量布地奈德/投药和剂量治疗结果    
Abstract:【Objective】To analyze the effect of different doses of budesonide combined with salbutamol on patients with acute attack of bronchial asthma. 【Methods】A total of 106 patients with acute attack of bronchial asthma treated in our hospital from October 2019 to October 2020 were selected. Patients with acute attack of bronchial asthma were randomly divided into the control group (with low-dose budesonide combined with salbutamol) and the observation group (with high-dose budesonide combined with salbutamol) by random table method. There were 53 cases in both groups. The curative effect, asthma symptom score before and after treatment, and serum inflammatory factors [hypersensitive C-reactive protein (hs-CRP), hypoxia inducible factor-1α(HIF-1α)] were compared between the two groups. Changes in lung function [forced vital capacity (FVC), forced expiratory volume (FEV1) in the first second, peak respiratory flow rate (PEF)], and adverse reactions were recorded and compared between the two groups. 【Results】The total effective rate of the observation group was 90.57% which was higher than that of the control group (75.47%) (P<0.05). After treatment, the symptom scores of day and night asthma in the observation group were lower than those of the control group (P<0.05). After treatment, the levels of hs-CRP, HIF-1α, TNF-α and IL-6 in the observation group were lower than those in the control group (P<0.05),while the FVC, FEV1 and PEF in the observation group were higher than those in the control group (P<0.05). The incidence of adverse reactions between the two groups were no significant statistical difference (P>0.05). 【Conclusion】The efficacy of high dose of budesonide combined with salbutamol in patients with acute attack of bronchial asthma is satisfactory, which can significantly improve the symptoms of bronchial asthma, down-regulate levels of hs-CRP, HIF-1α, TNF-α, and IL-6, and improve the lung function of patients with safety.
Key wordsAsthma/DT    Acute Disease    Albuterol/AD    Budesonide/AD    Treatment Outcome
收稿日期: 2023-03-22     
中图分类号:  R562.25  
通讯作者: *E-mail:1973456370@qq.com   
引用本文:   
许蕊, 宋丹. 不同剂量布地奈德联合沙丁胺醇治疗支气管哮喘急性发作的临床疗效[J]. 医学临床研究, 2024, 41(2): 240-243.
XU Rui, SONG Dan. Efficacy of Different Doses of Budesonide Combined with Salbutamol in the Treatment of Acute Attack of Bronchial Asthma. JOURNAL OF CLINICAL RESEARCH, 2024, 41(2): 240-243.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.02.023     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I2/240
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn